Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3.01%
operating margin TTM
-0.7%
revenue TTM
557.51 Million
revenue per share TTM
25.62$
valuation ratios | |
|---|---|
| pe ratio | -64.44 |
| peg ratio | 0.58 |
| price to book ratio | 2.79 |
| price to sales ratio | 2.17 |
| enterprise value multiple | 21.23 |
| price fair value | 2.79 |
profitability ratios | |
|---|---|
| gross profit margin | 67.56% |
| operating profit margin | -0.7% |
| pretax profit margin | -3.62% |
| net profit margin | -3.01% |
| return on assets | -1.44% |
| return on equity | -4.19% |
| return on capital employed | -0.4% |
liquidity ratio | |
|---|---|
| current ratio | 2.72 |
| quick ratio | 2.02 |
| cash ratio | 0.75 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 250.49 |
| operating cycle | 382.21 |
| days of payables outstanding | 83.61 |
| cash conversion cycle | 298.61 |
| receivables turnover | 2.77 |
| payables turnover | 4.37 |
| inventory turnover | 1.46 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.74 |
| long term debt to capitalization | 0.42 |
| total debt to capitalization | 0.42 |
| interest coverage | -0.25 |
| cash flow to debt ratio | 0.20 |
cash flow ratios | |
|---|---|
| free cash flow per share | 2.42 |
| cash per share | 7.77 |
| operating cash flow per share | 3.29 |
| free cash flow operating cash flow ratio | 0.74 |
| cash flow coverage ratios | 0.20 |
| short term coverage ratios | 6.98 |
| capital expenditure coverage ratio | 3.78 |
Frequently Asked Questions
When was the last time ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) reported earnings?
ANI Pharmaceuticals, Inc. (ANIP) published its most recent earnings results on 08-11-2024.
What is ANI Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)'s trailing twelve months ROE is -4.19%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ANI Pharmaceuticals, Inc. (ANIP) currently has a ROA of -1.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ANIP's net profit margin stand at?
ANIP reported a profit margin of -3.01% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ANIP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.72 in the most recent quarter. The quick ratio stood at 2.02, with a Debt/Eq ratio of 0.74.